Predictors of HbA1c levels in initial users of metformin.
Conclusions Diabetes duration was a relevant predictor of HbA1c levels after 6 and 18 months follow-up in patients initiating metformin treatment. Given the study design, no causal inference can be made. Our study suggests that prompt treatment intensification may be needed in patients who have a longer diabetes duration at treatment initiation.
PMID: 27552675 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Cholesterol | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Research | Study